![]() |
|
|
Vol. 293, Issue 3, 1009-1016, June 2000
-Aminobutyric
AcidA Receptor Modulation and Anesthesia1
Departments of Molecular Biology and Pharmacology (D.F.C., Y.H.,
K.R.N., A.S.E.), Anesthesiology (D.N., M.K., A.S.E.), and Psychiatry
(C.F.Z.), Washington University School of Medicine, St. Louis, Missouri
This study reports the actions of enantiomer pairs of anesthetic
steroids 3
5
P/ent-3
5
P and
3
5
P/ent-3
5
P as modulators of
-aminobutyric acid (GABA)A receptors and as anesthetics.
The enantiomers of structurally related 17-carbonitrile analogs also are examined. These studies were aimed at 1) determining whether the
steroid recognition site could distinguish between molecules differing
in shape, but not other physical properties (enantioselectivity); 2)
providing further insight into the structure-activity relationships of
anesthetic steroids; and 3) determining whether modulation of
GABAA receptor function correlates with anesthetic potency for anesthetic steroid enantiomers. Stereoselective actions of the
compounds were evaluated in four different bioassays: 1) noncompetitive displacement of
[35S]t-butylbicyclophosphorothionate from
the picrotoxin site of GABAA receptors present in rat brain
membrane preparations; 2) modulation of GABA currents in cultured rat
hippocampal neurons; 3) loss of righting reflex in tadpoles; and 4)
loss of righting reflex in mice. The data indicate that 5
-reduced
steroids, but not 5
-reduced steroids, show a high degree of
enantioselectivity/enantiospecificity in their actions as modulators of
GABAA receptors and as anesthetics. For all compounds
studied, the effects on GABAA receptor function closely
tracked with anesthetic effects. These data show that the anesthetic
steroid recognition site is capable of distinguishing enantiomers,
suggesting a protein-binding site of specific dimensions and shape. The
results are compatible either with a structural model of the binding
site that can accommodate 3
5
P, 3
5
P, and ent-3
5
P, but not ent-3
5
P, or
with two different binding sites for steroid anesthetics.
This article has been cited by other articles:
![]() |
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System Endocr. Rev., June 1, 2007; 28(4): 387 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Li, J. Bracamontes, B. W. Katona, D. F. Covey, J. H. Steinbach, and G. Akk Natural and Enantiomeric Etiocholanolone Interact with Distinct Sites on the Rat {alpha}1beta2{gamma}2L GABAA Receptor Mol. Pharmacol., June 1, 2007; 71(6): 1582 - 1590. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, D. F. Covey, J.-M. Alakoskela, P. K. J. Kinnunen, and J. H. Steinbach Enantiomers of Neuroactive Steroids Support a Specific Interaction with the GABA-C Receptor as the Mechanism of Steroid Action Mol. Pharmacol., June 1, 2006; 69(6): 1779 - 1782. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Smith, B. Oxley, S. Malpas, G. V. Pillai, and P. B. Simpson Compounds Exhibiting Selective Efficacy for Different {beta} Subunits of Human Recombinant {gamma}-Aminobutyric AcidA Receptors J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 601 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. W. Morris and J. Amin Insight into the Mechanism of Action of Neuroactive Steroids Mol. Pharmacol., July 1, 2004; 66(1): 56 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. I. Alakoskela, T. Soderlund, J. M. Holopainen, and P. K. J. Kinnunen Dipole Potential and Head-Group Spacing Are Determinants for the Membrane Partitioning of Pregnanolone Mol. Pharmacol., July 1, 2004; 66(1): 161 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Gonzales, C. L. Bell-Horner, M. A. M. de la Cruz, J. A. Ferrendelli, D. F. Covey, and G. H. Dillon Enantioselectivity of {alpha}-Benzyl-{alpha}-methyl-{gamma}-butyrolactone-Mediated Modulation of Anticonvulsant Activity and GABAA Receptor Function J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 677 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Darbandi-Tonkabon, B. D. Manion, W. R. Hastings, W. J. Craigen, G. Akk, J. R. Bracamontes, Y. He, T. V. Sheiko, J. H. Steinbach, S. J. Mennerick, et al. Neuroactive Steroid Interactions with Voltage-Dependent Anion Channels: Lack of Relationship to GABAA Receptor Modulation and Anesthesia J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 502 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Darbandi-Tonkabon, W. R. Hastings, C.-M. Zeng, G. Akk, B. D. Manion, J. R. Bracamontes, J. H. Steinbach, S. J. Mennerick, D. F. Covey, and A. S. Evers Photoaffinity Labeling with a Neuroactive Steroid Analogue. 6-AZI-PREGNANOLONE LABELS VOLTAGE-DEPENDENT ANION CHANNEL-1 IN RAT BRAIN J. Biol. Chem., April 4, 2003; 278(15): 13196 - 13206. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Burke and D. J. Henderson Chirality: a blueprint for the future Br. J. Anaesth., April 1, 2002; 88(4): 563 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Akwa, N. Ladurelle, D. F. Covey, and E.-E. Baulieu The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: Distinct mechanisms? PNAS, November 20, 2001; 98(24): 14033 - 14037. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Maller The elusive progesterone receptor in Xenopus oocytes PNAS, January 2, 2001; 98(1): 8 - 10. [Full Text] [PDF] |
||||